SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-096955
Filing Date
2015-03-18
Accepted
2015-03-18 16:09:59
Documents
6
Period of Report
2015-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d890084d8k.htm 8-K 22498
2 EX-10.1 d890084dex101.htm EX-10.1 134125
3 EX-10.2 d890084dex102.htm EX-10.2 56707
4 EX-10.3 d890084dex103.htm EX-10.3 103358
5 EX-99.1 d890084dex991.htm EX-99.1 7240
6 GRAPHIC g890084g08r95.jpg GRAPHIC 8494
  Complete submission text file 0001193125-15-096955.txt   337001
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 15710135
SIC: 2834 Pharmaceutical Preparations